Official Journal of Research Center for Gastroenterology and Liver Diseases
CrossRef
Works that cite this article, indexed by Crossref.
Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
Hepatitis Monthly 15(9) (2015)
Mahdiyar Pouresmaeeli; Seyed Moayed Alavian; Maryam Keshvari; Shima Salimi; Leila Mehrnoush
Vitamin D in Standard HCV Regimen (PEG-Interferon Plus Ribavirin), Its Effect on the Early Virologic Response Rate: A Clinical Trial
Razavi International Journal of Medicine 4(2) (2016)
Hasan Vosoghinia; Abbas Esmaeilzadeh; Azita Ganji; Seyed Mousal-Reza Hosseini; Saeid Amel Jamehdar; Maryam Salehi; Ali Bahari; Omid Ghanaei; Maryam Sahebari; Farnood Rajabzadeh; Kamran Ghaffarzadehgan; Ladan Goshayeshi
Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C
Hepatitis Monthly 13(5) (2013)
Reza Karbasi-Afshar; Amin Saburi
lasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?
Hepatitis Monthly 13(8) (2013)
Mohammad Abbasinazari; Bita Behnava; Yunes Panahi; Azita Hajhossein Talasaz; Shima Salimi; Maryam Keshvari; Leila Mehrnoush; Pegah karim; Mohammad Gholami Fesharaki; Mansour Asgharinia; Seyed Moayed Alavian
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline
Hepatitis Monthly 16(8) (2016)
Seyed Moayed Alavian; Behzad Hajarizadeh; Kamran Bagheri Lankarani; Heidar Sharafi; Nasser Ebrahimi Daryani; Shahin Merat; Minoo Mohraz; Masoud Mardani; Mohamad Reza Fattahi; Hossein Poustchi; Mehri Nikbin; Mahmood Nabavi; Peyman Adibi; Masood Ziaee; Bita Behnava; Mohammad Saeid Rezaee-Zavareh; Massimo Colombo; Hatef Massoumi; Abdul Rahman Bizri; Bijan Eghtesad; Majid Amiri; Ali Namvar; Khashayar Hesamizadeh; Reza Malekzadeh
Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network
Hepatitis Monthly 14(5) (2014)
Forough Sargolzaee Aval; Nazanin Behnaz; Mohamad Reza Raoufy; Seyed Moayed Alavian
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
World Journal of Gastroenterology 21(29) (2015)
Arghavan Haj-sheykholeslami
The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection
Indian Journal of Medical Microbiology 35(2) (2017)
Shahram Jalilian; Seyed Mahmoud Latifi; Manoochehr Makvandi; Ali Teimoori; Azarakhsh Azaran; Mehdi Parsanahad; Gholamabas Kayedani
Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients
Archives of Virology 159(11) (2014)
Farah Bokharaei-Salim; Hossein Keyvani; Mostafa Salehi-Vaziri; Farzin Sadeghi; Seyed Hamidreza Monavari; Leila Mehrnoush; Seyed Moayed Alavian
Hepatitis C Therapy – Related Haematological Side Effects are Associated with Treatment Outcome / Hematološka Neželjena Dejstva Terapije Hepatitisa C Su Povezana Sa Ishodom Lecenja
Serbian Journal of Experimental and Clinical Research 17(1) (2016)
Vuk R. Vukovic; Dejan Baskic; Zeljko Mijailovic; Predrag Djurdjevic
Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013
Hepatitis Monthly 13(11) (2013)
Nasser Ebrahimi Daryani; Seyed Moayed Alavian; Mohammad Hossein Somi; Mohammad Torabi-Nami
Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis
Experimental and Therapeutic Medicine (2018)
Lotfollah Davoodi; Babak Masoum; Mahmood Moosazadeh; Hamed Jafarpour; Mohammad Haghshenas; Tahoora Mousavi
Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C
Journal of Medical Virology 86(9) (2014)
Farzin Sadeghi; Farah Bokharaei-Salim; Mostafa Salehi-Vaziri; Seyed Hamidreza Monavari; Seyed Moayed Alavian; Shima Salimi; Rouhollah Vahabpour; Hossein Keyvani
Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
Clinics and Research in Hepatology and Gastroenterology 43(5) (2019)
Amitis Ramezani; Kazem Baesi; Mohammad Banifazl; Minoo Mohraz; Farzin Khorvash; Majid Yaran; Payam Tabarsi; Amir hosein Dalirrooyfard; Fatemeh Motevalli; Anahita Bavand; Arezoo Aghakhani
Adherence to Chronic Hepatitis C Treatment Regimen: First Report From a Referral Center in Iran
Hepatitis Monthly 13(6) (2013)
Saeedeh Ravi; Mohsen Nasiri Toosi; Iman Karimzadeh; Mehdi Ahadi-Barzoki; Hossein Khalili
Epidemiology of hepatitis C virus in Iran
World Journal of Gastroenterology 21(38) (2015)
Reza Taherkhani
IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C
Archives of Virology 162(1) (2017)
Parvaneh Sedighimehr; Shiva Irani; Fatemeh Sakhaee; Farzam Vaziri; Mohammadreza Aghasadeghi; Seyed Mehdi Sadat; Fatemeh Rahimi Jamnani; Abolfazl Fateh; Seyed Davar Siadat
Determination of Whether Vitiligo is a Contraindication to Interferon Therapy in Chronic Hepatitis C
Journal of Skin and Stem Cell 1(1) (2014)
Seyed Moayed Alavian
Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis
Hepatitis Monthly 16(4) (2016)
Farzin Sadeghi; Mostafa Salehi-Vaziri; Amir Almasi-Hashiani; Mohammad Gholami-Fesharaki; Reza Pakzad; Seyed Moayed Alavian
Risk Factors for Migraine Attacks in Patients Undergoing Treatment for Hepatitis C
Iranian Red Crescent Medical Journal 19(1) (2016)
Razie Salesi; Asieh Salesi; Faraidoon Haghdoost; Seyed Moayed Alavian